May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Complement Regulatory Proteins Are Important for the Survival of Human Retinoblastoma
J.–H. Sohn; E. Bodek; P. Jha; Y. Wang; P. Bora; H. Kaplan; N. Bora
Author Affiliations & Notes
  • J.–H. Sohn
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
  • E. Bodek
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
  • P. Jha
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
    Ophthalmology, Jones Eye Institute/ UAMS, Little Rock, AR
  • Y. Wang
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
  • P. Bora
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
    Ophthalmology, Jones Eye Institute/ UAMS, Little Rock, AR
  • H. Kaplan
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
  • N. Bora
    Ophthalmology, Kentucky Lions Eye Center, University of Louisville, Louisville, KY
    Ophthalmology, Jones Eye Institute/ UAMS, Little Rock, AR
  • Footnotes
    Commercial Relationships  J. Sohn, None; E. Bodek, None; P. Jha, None; Y. Wang, None; P. Bora, None; H. Kaplan, None; N. Bora, None.
  • Footnotes
    Support  EY13335, EY014623 HIGHWIRE EXLINK_ID="47:5:5161:1" VALUE="EY014623" TYPEGUESS="GEN" /HIGHWIRE , EY016205 HIGHWIRE EXLINK_ID="47:5:5161:2" VALUE="EY016205" TYPEGUESS="GEN" /HIGHWIRE , R24 EY016636 HIGHWIRE EXLINK_ID="47:5:5161:3" VALUE="EY016636" TYPEGUESS="GEN" /HIGHWIRE , Commonwealth of Kentucky Research Challenge Trust Fund and Research to Prevent Blindness, Inc. NY.
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5161. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Complement Regulatory Proteins Are Important for the Survival of Human Retinoblastoma
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      J.–H. Sohn, E. Bodek, P. Jha, Y. Wang, P. Bora, H. Kaplan, N. Bora; Complement Regulatory Proteins Are Important for the Survival of Human Retinoblastoma . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5161.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : This study was performed to investigate the role of complement regulatory proteins – MCP, DAF and CD59 in the survival of human retinoblastoma cells.

Methods: : Y79 human retinoblastoma cells (ATCC HTB 18) were obtained from the American Type Culture Collection and cultured under standard conditions using RPMI–1640 medium. The expression of CRPs was examined by flow cytometry and semi–quantative RT–PCR analysis. Monoclonal antibodies against human MCP, DAF and CD59 were used in flow cytometric analysis. Complement dependent cytotoxicity (CDC) was measured in vitro using Alamar Blue with blocking monoclonal antibody for MCP and CD59.

Results: : Our results of flow cytometry and RT–PCR analysis demonstrated that MCP and CD59 transcripts as well as proteins were abundantly expressed in retinoblastoma cells. In contrast, DAF was not expressed on these cells. Neutralization of MCP and CD59 caused increased death of retinoblastoma cells in vitro as determined by CDC assay.

Conclusions: : Functional suppression of complement regulatory proteins in vitro results in the death of retinoblastoma cells. Thus, neutralization of complement regulatory proteins on human retinoblastoma cells may have therapeutic potential and may serve as novel therapeutic agent in future.

Keywords: retinoblastoma • immunomodulation/immunoregulation • immune tolerance/privilege 
© 2006, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept